COVID-19 Clinical Programme Update

NEXT STORY
8,242 Orion Corporation A shares converted into B shares
PREV STORY
OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zafgen to Present at Upcoming Investor Conferences

BOSTON, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...

author_avatar
NASDAQ Market News

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2017

REDWOOD CITY, Calif., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma ...

author_avatar
NASDAQ Market News

Kessler Foundation Study Aims to Improve Learning among Adolescents with Brain Injury

EAST HANOVER, N.J., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation, a global leader ...

author_avatar
NASDAQ Market News